EUVIMEDEUVIMED entdecken
Übersichtsarbeit

miR‐210 in Ischemic Cardiovascular Disease: Functions, Mechanisms, and Therapeutic Potential

Wanqiu Zhang, Kexin Zhang, Yujie Ma, Zhenghui Tian, Chengxia Kan, Jingwen Zhang, Xiaodong Sun iD

Advanced Biology · 2026-05 · 10 (5)

DOI: 10.1002/adbi.202500653 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Biology, online erschienen am 18.05.2026. Verfasst von Wanqiu Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Shandong Provincial Key Medical and Health Laboratory of Endocrinology and Metabolic Diseases, Affiliated…. Hauptthemen laut MEDLINE: MicroRNAs, Myocardial Ischemia, Cardiovascular Diseases. Die Arbeit nennt 81 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation of Shandong Province, Young Talent of Lifting engineering for Science and Technology in Shandong.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemic cardiovascular disease remains a leading cause of morbidity and mortality worldwide despite advances in pharmacological, interventional, and rehabilitative therapies. Hypoxia‐inducible microRNA‐210 (miR‐210) has emerged as a central mediator of cellular adaptation to oxygen deprivation and ischemic injury. As a prototypical “hypoxamir,” miR‐210 regulates metabolic reprogramming, apoptosis, angiogenesis, and vascular remodeling, thereby influencing disease onset, progression, and repair. Its expression is governed by transcription factors, while downstream targets modulate mitochondrial function, DNA repair, and apoptotic signaling. Functionally, miR‐210 enhances cardiomyocyte survival, promotes endothelial migration and tube formation, attenuates fibrosis, and supports stem cell adaptation. Clinical studies reveal that circulating and exosomal miR‐210 correlate with infarct size, collateral formation, and prognosis, suggesting biomarker potential. Preclinical evidence further highlights therapeutic applications through mimics, antagomirs, nanoparticles, and stem cell–derived exosomes, though delivery and safety challenges remain. This review aims to synthesize current knowledge on the regulatory network and functional roles of miR‐210 in ischemic cardiovascular disease, and to evaluate its prospects as both a biomarker and a therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsMyocardial IschemiaCardiovascular DiseasesHumansAnimals

Stichwörter der Autor:innen

angiogenesisischemic cardiovascular diseasemiR‐210myocardial protectionregenerative therapy

Substanzen

MicroRNAsMIRN210 microRNA, human

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Shandong Provincial Key Medical and Health Laboratory of Endocrinology and Metabolic Diseases, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
  • Clinical Research Center, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
  • Department of Endocrinology and Metabolism, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

ORCID-Profile: Xiaodong Sun

Förderung

  • National Natural Science Foundation of China
  • National Natural Science Foundation of Shandong Province
  • Young Talent of Lifting engineering for Science and Technology in Shandong
  • Youth Innovation and Technology Support Program of Shandong Higher Education Institution

Zitieren

APA

Zhang, W., Zhang, K., Ma, Y., Tian, Z., Kan, C., Zhang, J., & Sun, X. (2026). miR‐210 in Ischemic Cardiovascular Disease: Functions, Mechanisms, and Therapeutic Potential. Advanced Biology, 10(5). https://doi.org/10.1002/adbi.202500653

Vancouver

Zhang W, Zhang K, Ma Y, Tian Z, Kan C, Zhang J, et al. miR‐210 in Ischemic Cardiovascular Disease: Functions, Mechanisms, and Therapeutic Potential. Advanced Biology. 2026;10(5). doi:10.1002/adbi.202500653

BibTeX
@article{Zhang2026,
  author = {Zhang, Wanqiu and Zhang, Kexin and Ma, Yujie and Tian, Zhenghui and Kan, Chengxia and Zhang, Jingwen and Sun, Xiaodong},
  title = {miR‐210 in Ischemic Cardiovascular Disease: Functions, Mechanisms, and Therapeutic Potential},
  journal = {Advanced Biology},
  year = {2026},
  volume = {10},
  number = {5},
  doi = {10.1002/adbi.202500653}
}
Kostenlos starten →